British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003)

HIV Medicine
A PoppaBritish Association for Sexual Health and HIV (BASHH)

Abstract

The widespread use of highly active antiretroviral therapy (HAART) has dramatically reduced HIV-associated morbidity and mortality where treatment has been made available. Very high levels of adherence to HAART are a prerequisite for a successful virological and immunological response. Low adherence increases the risk of treatment failure and disease progression. It is also likely to lead to further transmission of resistant viruses, and to have a negative impact on the cost effectiveness of HAART. Low adherence is difficult to predict, and this has two key implications for service provision. Firstly, HAART should not be withheld on the basis of assumptions about adherence. Secondly, support with adherence should be provided to all patients prescribed HAART. Our understanding of barriers to and enablers of high adherence, and the evidence base regarding effective interventions, is limited. Meta-analysis of randomized controlled trials available from the general literature suggests multiple interventions are required to maintain high adherence to chronic therapy. This document recommends a series of measures for adoption within HIV clinical care settings, based on evaluation of existing data. High adherence is a process, not a s...Continue Reading

References

Jan 1, 1993·AIDS Care·D Melvin, L Sherr
Jan 1, 1995·AIDS Care·R D MumaR B Pollard
Jun 24, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·L J EldredR D Moore
Oct 3, 1998·Annals of Internal Medicine·B H LernerN N Dubler
Jan 14, 2000·JAMA : the Journal of the American Medical Association·D V HavlirD D Richman
May 9, 2000·American Journal of Public Health·J D BambergerM H Katz
Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Chesney
Jul 6, 2000·Annals of Internal Medicine·D L PatersonN Singh
Jul 25, 2000·The Cochrane Database of Systematic Reviews·M HaddadS Rourke
Dec 19, 2000·Journal of General Internal Medicine·M O RigsbyB J Rounsaville
Feb 15, 2001·AIDS Care·D A MurphyUNKNOWN Adolescent Medicine HIV/AIDS Research Network
Mar 10, 2001·JAMA : the Journal of the American Medical Association·J J ParientiB Larouzé
May 5, 2001·BMJ : British Medical Journal·UNKNOWN UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance
May 16, 2001·Annals of Internal Medicine·H LiuN S Wenger
Jul 13, 2001·Antiviral Research·R G JainJ M Lenhard
Sep 28, 2001·The Annals of Pharmacotherapy·C S WendelS J Coons
Oct 2, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·F L AlticeG H Friedland
Nov 6, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·P CarrieriUNKNOWN APROCO study group
Dec 12, 2001·HIV Medicine·UNKNOWN BHIVA Writing Committee, UNKNOWN BHIVA Executive Committee
Dec 14, 2001·HIV Clinical Trials·E PontaliD Bassetti

❮ Previous
Next ❯

Citations

Sep 27, 2003·HIV Medicine·A PozniakUNKNOWN BHIVA Writing Committee BHIVA Executive Committee
Jul 2, 2005·AIDS Research and Human Retroviruses·Shabbar JaffarHilton Whittle
Mar 12, 2009·Health Policy and Planning·B S C UzochukwuO I Chukwuogo
Jul 2, 2008·HIV Medicine·T CoenenS Matic
Jul 2, 2008·HIV Medicine·S Mounier-JackR J Coker
Sep 25, 2012·HIV Medicine·A HughesF Boag
Aug 9, 2006·International Journal of Clinical Practice·M Nelson, M Lipman
Apr 20, 2012·International Journal of Clinical Practice·S Duncan, L Sathia
Sep 23, 2014·The Journal of Family Planning and Reproductive Health Care·Merrington OmakalwalaFortune Ncube
Nov 29, 2011·The Journal of Infection·T SolomonUNKNOWN National Encephalitis Guidelines Development and Stakeholder Groups
Jan 5, 2010·Patient Education and Counseling·Sigrid C J M VervoortJan C C Borleffs
Apr 6, 2005·Tropical Medicine & International Health : TM & IH·Shabbar JaffarMichael L Bennish
Jun 2, 2015·Clinical Journal of Oncology Nursing·Sandra L Spoelstra, Holly Sansoucie
Feb 6, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Silvia FaraoniValeria Ghisetti
Mar 27, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·E McDonaldO Blatchford
Jul 30, 2015·European Journal of Public Health·Caroline RumbleÉamonn O'Moore
Mar 23, 2017·Journal of the International Association of Providers of AIDS Care·Deborah Vitalis, Zelee Hill
Jun 25, 2008·International Journal of STD & AIDS·Sivapatham Shivasankar, Rachel Challenor
Jun 6, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sarah DameryKaveh Manavi
Jun 29, 2018·Sexually Transmitted Infections·Carys KnapperIrene Parker
Jul 5, 2007·The Journal of Family Planning and Reproductive Health Care·Sharon Moses, Mia Huengsberg
Mar 26, 2015·International Journal of Behavioral Medicine·Todd M RupparSabina M De Geest
Jul 21, 2006·The Cochrane Database of Systematic Reviews·S RuedaR H Glazier
Mar 15, 2019·HIV Medicine·Michael BradyIngrid Young
Mar 15, 2019·HIV Medicine·Dr Yvonne GilleeceMs Alison Wright

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.